Moderators
Nicolas ANDRE (CEPCM/CLIP²-AP-HM, Marseille, France), Richard Sullivan (King’s College, London, UK)
14h00
Welcome. Georges. LEONETTI - (Dean Faculty of Medecine, Aix-Marseille Université, Marseille, France)
14h15
Introduction. Richard SULLIVAN (King’s College, London, UK) 14h30
A need for LMIC? Bishal GYAWALI (Harvard, Boston, USA) 14h50
View from a leading center in Asia. Shripad BANAVALI (Tata Me- morial Hospital, Mumbai, India)
15h10
Gustave Roussy ‘s experience in a changing evolving environ- ment. Fabrice BARLESI (Gustave Roussy, Villejuif, France) 15h30
A pediatrician perspective. Eric BOUFFET (Hospital for Sick Child- ren, Toronto, Canada)
15h50 Questions 16h10
Are LMICs new partners for early phase clinical trials? View from a pharmaceutical company.
Anthony MOREL (Roche, Bale, Switzerland) 16h30
Expanding the Science of Metronomic Therapy. Debasish ROY- CHOWDHURY (Partner Therapeutics, Lexington, USA)
16h50
Role of academic journals: the editor’s view. Diana ROMERO (Chief Editor, Nature Reviews Clinical Oncology)
17h10 Questions & Conclusion Faculty
Nicolas ANDRE, Olivier CHINOT, Julien COLLE, Régis COSTELLO, Laetitia DAHAN, Jean Laurent DEVILLE, Florence DUFFAUD, Muriel DULUC, Caroline GAUDY, René GEROLAMI, Laurent GREILLIER, Jean-Jacques GROB, Eric GUEDJ, Arnaud JEANSON, Nausicaa MALISSEN, Marie MEURER, Gérard MICHEL, Pascale TOMASINI, Sébastien SALAS, Emeline TABOURET, David TAIEB.
CENTRE D’ESSAIS PRÉCOCES EN CANCÉROLOGIE DE MARSEILLE
AP-HM CLIP²
EARLY PHASE CLINICAL TRIALS
& GLOBAL ONCOLOGY : A NEW DEAL ?
Is pleased to invite you to the 10th seminar dedicated to phase I oncology
VILLA GABY – FRIDAY JUNE 18TH 2021
Inscrivez-vous en ligne en scannant le QR-code
